VEGFA and pathological myopia: Increased level of TGFβ-2 in AH of these subjects has been associated with intraocular pressure elevation and occurrence of secondary glaucoma [28]; (c) monitoring the response to anti-vascular endothelial growth factor (VEGF) drug treatment for choroidal neovascularization secondary to age-related macular degeneration or pathologic myopia.